| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8821434 | Clinical Imaging | 2018 | 22 Pages |
Abstract
Castleman disease (CD) is a rare lymphoproliferative disorder of unknown etiology that may occur anywhere in the lymphatic system. Imaging plays an important role in detecting and staging this disease. Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) combines the metabolic information derived from nuclear medical imaging with the high soft tissue resolution from MRI. We review the features of CD in standard diagnostic imaging, analyze the specific imaging findings of CD in FDG-PET/MRI and discuss a potential benefit of PET/MRI based on the case of a 15-year-old female patient with retroperitoneal CD.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Negin Rassouli, Verena C. Obmann, Linda M. Sandhaus, Karin A. Herrmann,